JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 40 No. 5 737-746
© 1999 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drzezga, A.
Right arrow Articles by Bartenstein, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drzezga, A.
Right arrow Articles by Bartenstein, P.

18F-FDG PET Studies in Patients with Extratemporal and Temporal Epilepsy: Evaluation of an Observer-Independent Analysis

Alexander Drzezga, Stephan Arnold, Satoshi Minoshima, Soheyl Noachtar, Johann Szecsi, Peter Winkler, Wolfgang Römer, Klaus Tatsch, Wolfgang Weber and Peter Bartenstein

Department of Nuclear Medicine, Technische Universität, München
Departments of Neurology, Neurosurgery and Nuclear Medicine, Ludwig-Maximilians-Universtät, München, Germany
Division of Nuclear Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan

Correspondence: For correspondence or reprints contact: Alexander Drzezga, MD, Nuklear-medizinische, Klinik und Poliklinik, der Technischen Universität München, Klinikum rechts der Isar, Ismaninger Str. 22, 81675 München, Germany.

ABSTRACT

The aim of this study was to evaluate an observer-independent analysis of 18F-fluorodeoxyglucose (FDG) PET studies in patients with temporal or extratemporal epilepsy. Methods: Twenty-seven patients with temporal epilepsy and 22 patients with extratemporal epilepsy were included in the study. All patients with temporal epilepsy and 7 patients with extratemporal epilepsy underwent surgical treatment. In patients who showed significant postoperative improvement (temporal, n = 23; extratemporal, n = 6), the epileptogenic focus was assumed to be located in the area of surgical resection. In extratemporal epilepsy patients who did not undergo surgery, the focus localization was determined using a combination of semiology, ictal and interictal electroencephalography, [99mTc]ethyl cysteinate dimer SPECT, MRI and [11C]flumazenil PET. Visual analysis was performed by two experienced and two less experienced blinded observers using sagittal, axial and coronal images. In the automated analysis after anatomic standardization and generation of three-dimensional stereotactic surface projections (SSPs), a pixelwise comparison of 18F-FDG uptake with an age-matched reference database (n = 20) was performed, resulting in z score images. Pixels with the maximum deviation were detected, summarized and attached to one of 20 predefined surface regions of interest. For comparison with 18F-FDG PET and MR images, three-dimensional overlay images were generated. Results: In patients with temporal epilepsy, the sensitivity was comparable for visual and observer-independent analysis (three-dimensional SSP 86%, experienced observers 86%–90%, less experienced observers 77%–86%). In patients with extratemporal epilepsy, three-dimensional SSP showed a significantly higher sensitivity in detecting the epileptogenic focus (67%) than did visual analysis (experienced 33%–38%, each less experienced 19%). In temporal lobe epilepsy, there was moderate to good agreement between the localization found with three-dimensional SSP and the different observers. In patients with extratemporal epilepsy, there was a high interobserver variability and only a weak agreement between the localization found with three-dimensional SSP and the different observers. Although three-dimensional SSP detected multiple lesions more often than visual analysis, the determination of the highest deviation from the reference database allowed the identification of the epileptogenic focus with a higher accuracy than subjective criteria, especially in extratemporal epilepsy. Conclusion: Three-dimensional SSP increases sensitivity and reduces observer variability of the analysis of 18F-FDG PET images in patients with extratemporal epilepsy and is, therefore, a useful tool in the evaluation of this patient group. The benefit of this analytical approach in patients with temporal epilepsy is less apparent.

Key Words: extratemporal • epilepsy • 18F-fluorodeoxyglucose • PET • computer-assisted image processing




This article has been cited by other articles:


Home page
JNMHome page
T. J. O'Brien, K. Miles, R. Ware, M. J. Cook, D. S. Binns, and R. J. Hicks
The Cost-Effective Use of 18F-FDG PET in the Presurgical Evaluation of Medically Refractory Focal Epilepsy
J. Nucl. Med., June 1, 2008; 49(6): 931 - 937.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Drzezga, T. Grimmer, M. Riemenschneider, N. Lautenschlager, H. Siebner, P. Alexopoulus, S. Minoshima, M. Schwaiger, and A. Kurz
Prediction of Individual Clinical Outcome in MCI by Means of Genetic Assessment and 18F-FDG PET
J. Nucl. Med., October 1, 2005; 46(10): 1625 - 1632.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Drzezga, M. Riemenschneider, B. Strassner, T. Grimmer, M. Peller, A. Knoll, S. Wagenpfeil, S. Minoshima, M. Schwaiger, and A. Kurz
Cerebral glucose metabolism in patients with AD and different APOE genotypes
Neurology, January 11, 2005; 64(1): 102 - 107.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
T Siessmeier, W A Nix, J Hardt, M Schreckenberger, U T Egle, and P Bartenstein
Observer independent analysis of cerebral glucose metabolism in patients with chronic fatigue syndrome
J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 922 - 928.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
V. Bouilleret, M. P. Valenti, E. Hirsch, F. Semah, and I. J. Namer
Correlation Between PET and SISCOM in Temporal Lobe Epilepsy
J. Nucl. Med., August 1, 2002; 43(8): 991 - 998.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
L. Jager, K. J. Werhahn, A. Hoffmann, S. Berthold, V. Scholz, J. Weber, S. Noachtar, and M. Reiser
Focal Epileptiform Activity in the Brain: Detection with Spike-related Functional MR Imaging—Preliminary Results
Radiology, June 1, 2002; 223(3): 860 - 869.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. J. Van Laere, J. Warwick, J. Versijpt, I. Goethals, K. Audenaert, B. Van Heerden, and R. Dierckx
Analysis of Clinical Brain SPECT Data Based on Anatomic Standardization and Reference to Normal Data: An ROC-Based Comparison of Visual, Semiquantitative, and Voxel-Based Methods
J. Nucl. Med., April 1, 2002; 43(4): 458 - 469.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Henkel, S. Noachtar, M. Pfander, and H. O. Luders
The localizing value of the abdominal aura and its evolution: A study in focal epilepsies
Neurology, January 22, 2002; 58(2): 271 - 276.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
I. ANGHELESCU, C. J. KLAWE, P. BARTENSTEIN, and A. SZEGEDI
Normal PET After Long-Term ECT
Am J Psychiatry, September 1, 2001; 158(9): 1527 - 1527.
[Full Text] [PDF]


Home page
JNMHome page
T. J. O'Brien, R. J. Hicks, R. Ware, D. S. Binns, M. Murphy, and M. J. Cook
The Utility of a 3-Dimensional, Large-Field-Of-View, Sodium Iodide Crystal-Based PET Scanner in the Presurgical Evaluation of Partial Epilepsy
J. Nucl. Med., August 1, 2001; 42(8): 1158 - 1165.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1999 by the Society of Nuclear Medicine.